IMJUDO

TREMELIMUMAB · AstraZeneca Pharmaceuticals LP

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for IMJUDO, covering 2022-10-21 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI